Gene by Gene

Parent firm Gene by Gene calls the law "brief and vague" and is pushing for ancestry testing to be exempt from the provision of the genetic privacy statute.

The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.

Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.

NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper.

Gene by Gene will later this year debut a genetic disease carrier screening service focused on Jewish populations in the US.

A new Y chromosome sequencing service could lead to a new generation of more informative microarrays for genetic genealogy and ancestry testing.

The term 'consumer genomics' may have a catch-all ring to it, but for the time being it means ancestry testing and genetic genealogy, including for companies such as 23andMe, which built its business on relaying both personal health information and ancestral information back to c

RootsTech is a family history conference held each year in Salt Lake City.

Gene by Gene can still the return mutation status of the BRCA1 and BRCA2 genes to US and Canadian customers via its clinical and research-focused microarrays, despite a new agreement with Myriad Genetics that prohibits Gene by Gene from offering its BRCA single-gene and gene pane

NEW YORK (GenomeWeb News) – Gene by Gene and Myriad Genetics today announced that they have reached a settlement in their litigation over BRCA testing patents held by Myriad, the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, and the Trust

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.